Stage IIIC Colorectal Cancer AJCC v7 Recruiting Phase 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0090390 (Stage IIIC Colorectal Cancer AJCC v7)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03396926Pembrolizumab, Capecitabine, and Bevacizumab in Treating Patients With Microsatellite Stable Colorectal Cancer That Is Locally Advanced, Metastatic, or Cannot Be Removed by SurgeryTreatment